9 October 2026

CPHI Milan 2026: Conversations Moving Forward

Farmak International concluded three intensive days at CPHI Milan 2026 with strong partner interest in complex generics, injectables, and future collaboration.

This October, Farmak International welcomed existing and prospective partners at stand 14D34 in the FDF category. Over three busy days, our team discussed new projects, portfolio opportunities, and potential cooperation areas with partners worldwide.

CPHI Milan 2026: Conversations Moving Forward. Photo 11

This year, our priority focus included:

  ▷ Long-acting injectables

  ▷ Peptides

  ▷ Depot hormones

  ▷ Contrast media for CT & MRI

  ▷ Iron deficiency products

  ▷ Advanced delivery formats, including pre-filled syringes, vials, pens and autoinjectors

Colleagues from every region where Farmak International operates joined us in Milan. Our meeting schedules remained fully booked throughout the event.

CPHI Milan 2026: Conversations Moving Forward. Photo 12

Our meetings reinforced several trends gaining importance across the industry: growing demand for complex generics and advanced delivery systems, greater focus on reliable development and manufacturing capabilities, and increasing need for partnership models adapted to individual markets.

These trends align with the areas Farmak International is investing in as we expand internationally. With products already reaching 60+ markets, our focus is on strengthening the portfolio, capabilities, and partnerships that will support growth in complex generics and advanced delivery systems.

CPHI Milan 2026: Conversations Moving Forward. Photo 13

Thank you to everyone who visited us at 14D34, shared their plans, and explored future opportunities with our team. Many of the conversations started in Milan are only beginning.

See you next year at CPHI Worldwide in Frankfurt.

Back to Press Releases